Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02895932 · ClinicalTrials.gov registry record · NA
Serotonin and Amyloidopathy
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT02895932 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 27 participants.
The verdict
NCT02895932, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if changes in brain serotonin affects the accumulation of amyloid in the brain. The investigators will use brain imaging methods to measure the amount of serotonin and amyloid in the brain of individuals with Parkinson's Disease (PD) and otherwise healthy older people. PD participants will undergo repeat brain imaging to assess amyloid accumulation two years after their first brain imaging session. All participants will undergo examinations to assess their motor function, and asked questions to assess their mood and thinking.
Interventions
- RADIATION PET imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02895932
The ClinicalTrials.gov registry entry for NCT02895932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET imaging is the first listed.
NCT02895932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02895932 about?
NCT02895932 is a clinical study titled "Serotonin and Amyloidopathy". The purpose of this study is to determine if changes in brain serotonin affects the accumulation of amyloid in the brain. The investigators will use brain imaging methods to measure the amount of serotonin and amyloid in the brain of individuals with Parkinson's Disease (PD) and otherwise healthy ol...
What is the current status of trial NCT02895932?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2015-01. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02895932?
The interventions under investigation include: PET imaging (RADIATION).
Who is sponsoring clinical trial NCT02895932?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.